284 related articles for article (PubMed ID: 24257605)
1. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus.
Prentoe J; Serre SB; Ramirez S; Nicosia A; Gottwein JM; Bukh J
J Virol; 2014 Feb; 88(3):1725-39. PubMed ID: 24257605
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.
Velázquez-Moctezuma R; Galli A; Law M; Bukh J; Prentoe J
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487284
[TBL] [Abstract][Full Text] [Related]
3. Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization.
Prentoe J; Jensen TB; Meuleman P; Serre SB; Scheel TK; Leroux-Roels G; Gottwein JM; Bukh J
J Virol; 2011 Mar; 85(5):2224-34. PubMed ID: 21123377
[TBL] [Abstract][Full Text] [Related]
4. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
[TBL] [Abstract][Full Text] [Related]
5. Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.
Prentoe J; Velázquez-Moctezuma R; Foung SK; Law M; Bukh J
Hepatology; 2016 Dec; 64(6):1881-1892. PubMed ID: 27351277
[TBL] [Abstract][Full Text] [Related]
6. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
[TBL] [Abstract][Full Text] [Related]
7. Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A.
Velázquez-Moctezuma R; Law M; Bukh J; Prentoe J
PLoS Pathog; 2017 Feb; 13(2):e1006214. PubMed ID: 28231271
[TBL] [Abstract][Full Text] [Related]
8. In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus.
Olesen CH; Augestad EH; Troise F; Bukh J; Prentoe J
PLoS Pathog; 2021 Jul; 17(7):e1009720. PubMed ID: 34280245
[TBL] [Abstract][Full Text] [Related]
9. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus-Escape Studies for Human Monoclonal Antibody AR4A Reveal Isolate-Specific Resistance and a High Barrier to Resistance.
Velázquez-Moctezuma R; Galli A; Law M; Bukh J; Prentoe J
J Infect Dis; 2019 Jan; 219(1):68-79. PubMed ID: 30102355
[TBL] [Abstract][Full Text] [Related]
11. Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.
Prentoe J; Velázquez-Moctezuma R; Augestad EH; Galli A; Wang R; Law M; Alter H; Bukh J
Proc Natl Acad Sci U S A; 2019 May; 116(20):10039-10047. PubMed ID: 31040211
[TBL] [Abstract][Full Text] [Related]
12. HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice.
Prentoe J; Verhoye L; Velázquez Moctezuma R; Buysschaert C; Farhoudi A; Wang R; Alter H; Meuleman P; Bukh J
Gut; 2016 Dec; 65(12):1988-1997. PubMed ID: 26589670
[TBL] [Abstract][Full Text] [Related]
13. Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.
Lavie M; Sarrazin S; Montserret R; Descamps V; Baumert TF; Duverlie G; Séron K; Penin F; Dubuisson J
J Virol; 2014 Sep; 88(18):10584-97. PubMed ID: 24990994
[TBL] [Abstract][Full Text] [Related]
14. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
15. Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteins.
Koutsoudakis G; Dragun J; Pérez-Del-Pulgar S; Coto-Llerena M; Mensa L; Crespo G; González P; Navasa M; Forns X
PLoS One; 2012; 7(12):e52651. PubMed ID: 23300734
[TBL] [Abstract][Full Text] [Related]
16. Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.
Serre SB; Krarup HB; Bukh J; Gottwein JM
J Virol; 2013 Dec; 87(23):12776-93. PubMed ID: 24049176
[TBL] [Abstract][Full Text] [Related]
17. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
[TBL] [Abstract][Full Text] [Related]
18. Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry.
Prentoe J; Bukh J
Front Immunol; 2018; 9():2146. PubMed ID: 30319614
[TBL] [Abstract][Full Text] [Related]
19. Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.
Guan M; Wang W; Liu X; Tong Y; Liu Y; Ren H; Zhu S; Dubuisson J; Baumert TF; Zhu Y; Peng H; Aurelian L; Zhao P; Qi Z
J Biol Chem; 2012 Oct; 287(42):35631-35645. PubMed ID: 22927442
[TBL] [Abstract][Full Text] [Related]
20. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
Li YP; Ramirez S; Mikkelsen L; Bukh J
J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
